Clinical signs and diagnosis of inherited metabolic disease in dogs and cats;Klinik und Diagnostik Angeborener Stoffwechselkrankheiten bei Hund und Katze

Kleintierpraxis

Volumn 52, Issue 4, 2007, Pages 209-215

  Sewell, Adrian C ^a   Meyer, Karin ^b   Böttcher, Irene C ^c   Tipold, Andrea ^c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Biocontrol GmbH   (Germany)

^c UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Cat; Diagnosis; Dog; Inherited metabolic disease; Screening

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

EID: 34247610916     PISSN: 00232076     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. ABRAMSON CJ, PLATT SR, JAKOBS C, VERHOEVEN NM, DENNIS R, GAROSI L, SHELTON GD (2003): L-2-hydroxyglutaric aciduria in Staffordshire Bull terriers. J Vet Intern Med 17: 551-556.
2. ALROY J, SCHELLING SH, THALHAMMER JG, RAGHAVAN SS, NATOWICZ MR, PRENCE EM, ORGAD U (1994): Adult onset lysosomal storage disease in a Tibetan terrier: clinical, morphological and biochemical studies. Acta Neuropathol 84 (6): 658-663.
3. AUCLAIR D, HOPWOOD JJ, BROOKS DA, LEMONTT JF, CRAWLEY AC (2003): Replacement therapy in mucopolysaccharidosis type VI: advantages of early onset of therapy. Mol Genet Metab 78:163-174.
4. BARKER CG, BLAKEMORE WF, DELL A, PALMER AC, TILLER PR, WINCHESTER BG (1986): GM1 gangliosidosis (type 1) in a cat. Biochem J 235:151-158.
5. BLAKEMORE WF, HEATH MF, BENNETT MJ, CROMBY CH, POLLITT RJ (1988): Primary hyperoxaluria and L-glyceric aciduria in the cat. J Inherit Metab Dis 11 (Suppl 2): 215-217.
6. BRENNER O, WAKSHLAG JJ, SUMMERS BA, DE LAHUNTA A (2000): Alaskan Husky encephalopathy - a canine neurodegenerative disorder resembling subacute necrotizing encephalomyelopathy (Leigh syndrome). Acta Neuropathol 100: 50-62.
7. CASAL ML, GIGER U, BOVEE KC, PATTERSON DF (1995):. Inheritance of cystinuria and renal defect in Newfoundlands. J Am Vet Med Assoc 207: 1585-1589.
8. CHERQUI S, SEVIN C, HAMARD G, KALATZIS V, SICH M, PEQUIGNOT MO, GOGAT K, ABITBOL M, BROYER M, GUBLER MC, ANTIGNAC C (2002): Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis. Mol Cell Biol 22: 7622-7632.
9. COZZI F, VITE CH, WENGER DA, VICTORIA T, HASKINS ME (1998): MRI and electrophysiological abnormalities in a case of canine globoid cell leucodystrophy. J Small Anim Pract 39: 401-405.
10. CRAWLEY AC, BROOKS DA, MULLER VJ, PETERSEN BA, ISAAC EL, BIELICKI J, KING BM, BOULTER CD, MOORE AJ, FAZZALARI NL, ANSON DS, BYERS S, HOPWOOD JJ (1996): Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome. J Clin Invest 97: 1864-1873.
11. CRAWLEY AC, YOGALINGAM G, MULLER VJ, HOPWOOD JJ (1998): Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes. J Clin Invest 101 (1): 109-119.
12. DE LORENZI D, BERNARDINI M, PUMAROLA M (2005): Primary hyperoxaluria (L-glyceric aciduria) in a cat. J Feline Med Surg 7: 357-361.
13. ELLINWOOD NM, VITE CH, HASKINS ME (2004): Gene therapy for lysosomal storage diseases: the lessons and promise of animal models. J Gene Med 6: 481-506.
14. FINSTERER J (2004): Mitochondriopathies. Eur J Neurol 11: 163-186.
15. FINSTERER J, MILVAY E (2004): Stress lactate in mitochondrial myopathy under constant, unadjusted workload. Eur J Neurol 11: 811-816.
16. GAROSILS, PENDERIS J, McCONNELL JF, JAKOBS C (2005): L-2-Hydroxyglutaric aciduria in a West Highland white terrier. Vet Rec 156: 145-147.
17. GARROD A (1902): The incidence of alkaptonuria. A study in clinical individuality. Lancet 1:1616-1620.
18. HARDY RM, STEVENS JB, STOWE CM (1975): Chronic progressive hepatitis in Bedlington terriers associated with elevated liver copper concentrations. Minnesota Veterinarian 15:13-24.
19. HASKINS M, CASAL M, ELLINWOOD NM, MELNICZEK J, MAZRIER H, GIGER U (2002): Animal models for mucopolysaccharidoses and their clinical relavance. Acta Paediatr Suppl 439: 88-97.
20. JEZYK PF, HASKINS ME, PATTERSON DF, MELLMAN WJ, GRENNSTEIN M (1977): Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: a model of Maroteaux-Lamy syndrome. Science 198: 834.
21. JIAN Z, ALLEY MR, CAYZER J, SWINNEY GR (1990): Lafora's disease in an epileptic Basset hound. N Z Vet J 38 (2): 75-79.
22. KAISER E, KRAUSER K, SCHWARTZ-PORSCHE D (1991): Lafora-Erkrankung (progressive Myoklonusepilepsie) beim Bassethund - Möglichkeiten der Früherkennung mittels Muskelbiopsie? Vergleich der Einschlusskö rperchen in Hirn und Muskel, dargestellt an zwei ausgewerteten Fällen. Tierärztl Prax 19 (K): 290-295.
23. MATIASEK K, KOPP A, STIERSTORFER B, FISCHER A, SCHMAHL W (2002): Clinicopathologic survey on Leigh Syndrome in Yorkshire Terriers. In: ESVN/ECVN Proceedings of the 15th Annual Symposium, 2002; Philadelphia, USA.
24. MÜLLER G, ALLDINGER S, MORITZ A, ZURBRIGGEN A, KIRCHOF N, SEWELL A, BAUMGÄRTNER W (2001): GM1-gangliosidosis in Alaskan Huskies: clinical and pathologic findings. Vet Pathol 38: 281-290.
25. MUNANA KR, LUTTGEN PJ, THRALL MA, MTTCHELL TW, WENGER DA (1994):. Neurological manifestations of Niemann-Pick disease type C in cats. J Vet Intern Med 8 (2): 117-121.
26. OHSHIMA T, MURRAY GJ, SWAIM WD et al. (1997): Alpha-galactosidase deficient mice: a model of Fabry disease. Proc Natl Acad Sci USA 94: 2540-2544.
27. OLBY NJ, CHAN KK,TARGETT MP, HOULTON JEF (1997): Suspected mitochondrial! myopathy in a Jack Russell terrier. J Small Anim Pract 38: 213-216.
28. PACIELLO O, MAIOLINO P, FATONE G, PAPPARELLA S (2003): Mitochondrial myopathy in a German shepherd dog. Vet Pathol 40: 507-511.
29. PHANEUF D, WAKAMATSU N, HUANG JQ et al. (1996): Dramatically different phenotypes in mouse models of human Tay Sachs and Sandhoff diseases. Hum Mol Genet 5:1-14.
30. PODELL M, SHELTON GD, NYHAN WL, WAGNER SO, GENDERS A, OGLESBEE M, FENNER WR (1996): Methylmalonic aciduria and malonic aciduria in a dog with progressive encephalomyelopathy. Metab Brain Dis 11: 239-247.
31. SALVADORI C, MODENATO M, CORLAZZOLIDS, ARISPICI M, CANTILE C (2005): Clinicopathological features of globoid cell leucodystrophy in cats. J Comp Path 132: 350-356.
32. SCHOEMAN T, WILLIAMS J, VAN WILPE E (2002): Polyglucosan storage disease in a dog resembling Lafora's disease. JVet Intern Med 16: 201-207.
33. SEWELL AC, MORITZ A, DURAN M (1997): D-(+)-Glyceric aciduria in an Afghan Hound. J Inherit Metab Dis 20: 395-396.
34. SILVERSTEIN-DOMBRWOSKI DC, CARMICHAEL KP, WANG P, O'MALLEY TM, HASKINS ME, GIGER U (2004): Mucopolysaccharidosis type VII in a German Shepherd dog. J Am Vet Med Assoc 224: 532-533.
35. SISK DB, LEVESQUE DC, WOOD BA, STYER EL (1990): Clinical and pathological features of ceroid lipofuscinosis in two Australian cattle dogs. J Am Vet Med Assoc 197 (3): 361-364.
36. SISO S, NAVARRO C, HANZLICEK D, VANDEVELDE M (2004): Adult onset thalamocerebellar degeneration in dogs associated to neuronal storage of ceroid lipopigment. Acta Neuropathol 108: 386-392.
37. SKELLY BJ, FRANKLIN RJM (2002): Recognition and diagnosis of lysosomal storage diseases in the cat and dog. J Vet Intern Med 16: 133-141.
38. SPERL W (1992): KlinischerVerdacht auf angeborene Stoffwechselstö rungen. Wien Klin Wochenschr 104: 497-502.
39. VANDEVELDE M, FATZER R (1980): Neuronal ceroid-lipofuscinosis in older dachshunds. Vet Pathol 17 (6): 686-692.
40. VICINI DS, WHEATON LG, ZACHARY JF, PARKERS AJ (1988): Peripheral nerve biopsy for diagnosis of globoid cell leukodystrophy in a dog. J Vet Anim Med Assoc 192 (8): 1087-1090.
41. WAKSHLAG JJ, DE LAHUNTA A, ROBINSON T, COOPER BJ, BRENNER O, O'TOOLETD, OLSON J, BECKMAN KB, GLASS E, REYNOLDS AJ (1999): Subacute necrotising encephalopathy in an Alaskan husky. J Small Anim Prac 40: 585-589.
42. WHITFIELD P, JOHNSON AW, DUNN KA, DELAUCHE AJN, WINCHESTER BG, FRANKLIN RJM (2000): GM1-gangliosidosis in a cross-bred dog confirmed by detection of GM1-ganglioside using electrospray ionisation-tandem mass spectrometry. Acta Neuropathol 100: 409-414.